BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34916608)

  • 1. Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure.
    Lai Q; Liu FM; Rao WL; Yuan GY; Fan ZY; Zhang L; Fu F; Kou JP; Yu BY; Li F
    Acta Pharmacol Sin; 2022 Aug; 43(8):2003-2015. PubMed ID: 34916608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway.
    Ren B; Feng J; Yang N; Guo Y; Chen C; Qin Q
    Int Immunopharmacol; 2021 Sep; 98():107841. PubMed ID: 34153662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway.
    Zeng Z; Wang Q; Yang X; Ren Y; Jiao S; Zhu Q; Guo D; Xia K; Wang Y; Li C; Wang W
    Phytomedicine; 2019 Sep; 62():152949. PubMed ID: 31102891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SOX2OT/Smad3 feedback loop promotes myocardial fibrosis in heart failure.
    Ou Y; Liao C; Li H; Yu G
    IUBMB Life; 2020 Nov; 72(11):2469-2480. PubMed ID: 32959533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice.
    Li X; Han D; Tian Z; Gao B; Fan M; Li C; Li X; Wang Y; Ma S; Cao F
    Cell Physiol Biochem; 2016; 39(4):1521-36. PubMed ID: 27614871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Contractility Modulation Attenuate Myocardial Fibrosis by Inhibiting TGF-β1/Smad3 Signaling Pathway in a Rabbit Model of Chronic Heart Failure.
    Zhang F; Dang Y; Li Y; Hao Q; Li R; Qi X
    Cell Physiol Biochem; 2016; 39(1):294-302. PubMed ID: 27344462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction.
    Ma Y; Kuang Y; Bo W; Liang Q; Zhu W; Cai M; Tian Z
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1/SMAD3 Regulates Programmed Cell Death 5 That Suppresses Cardiac Fibrosis Post-Myocardial Infarction by Inhibiting HDAC3.
    Weng L; Ye J; Yang F; Jia S; Leng M; Jia B; Xu C; Zhao Y; Liu R; Xiong Y; Zhou Y; Zhao J; Zheng M
    Circ Res; 2023 Jul; 133(3):237-251. PubMed ID: 37345556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The crystallin alpha B (HSPB5)-tripartite motif containing 33 (TRIM33) axis mediates myocardial fibrosis induced by angiotensinogen II through transforming growth factor-β (TGF-β1)-Smad3/4 signaling.
    Wei T; Du Y; Shan T; Chen J; Shi D; Yang T; Wang J; Zhang J; Li Y
    Bioengineered; 2022 Apr; 13(4):8836-8849. PubMed ID: 35333698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα.
    Lyu H; Li X; Wu Q; Hao L
    J Pharmacol Sci; 2019 Sep; 141(1):70-78. PubMed ID: 31611175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cartilage intermediate layer protein-1 alleviates pressure overload-induced cardiac fibrosis via interfering TGF-β1 signaling.
    Zhang CL; Zhao Q; Liang H; Qiao X; Wang JY; Wu D; Wu LL; Li L
    J Mol Cell Cardiol; 2018 Mar; 116():135-144. PubMed ID: 29438665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
    Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
    Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model.
    Hong SK; Choo EH; Ihm SH; Chang K; Seung KB
    Metabolism; 2017 Nov; 76():42-55. PubMed ID: 28987239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20(S)-ginsenoside Rg3 exerts anti-fibrotic effect after myocardial infarction by alleviation of fibroblasts proliferation and collagen deposition through TGFBR1 signaling pathways.
    Xu H; Miao H; Chen G; Zhang G; Hua Y; Wu Y; Xu T; Han X; Hu C; Pang M; Tan L; Liu B; Zhou Y
    J Ginseng Res; 2023 Nov; 47(6):743-754. PubMed ID: 38107395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANO1 relieves pressure overload-induced myocardial fibrosis in mice by inhibiting TGF-β/Smad3 signaling pathway.
    Kong JC; Miao WQ; Wang Y; Zhou SF
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8493-8501. PubMed ID: 32894555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
    Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
    J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-β1/Smad3 signalling pathway.
    Li N; Hang W; Shu H; Zhou N
    J Cell Mol Med; 2022 Aug; 26(16):4548-4555. PubMed ID: 35861038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengzhan Shengmai capsule attenuates cardiac fibrosis in post-myocardial infarction rats by regulating LTBP2 and TGF-β1/Smad3 pathway.
    Wang M; Wang M; Zhao J; Xu H; Xi Y; Yang H
    Phytomedicine; 2023 Jul; 116():154849. PubMed ID: 37163903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte-specific loss of RNA polymerase II subunit 5-mediating protein causes myocardial dysfunction and heart failure.
    Zhang J; Sheng J; Dong L; Xu Y; Yu L; Liu Y; Huang X; Wan S; Lan HY; Wang H
    Cardiovasc Res; 2019 Sep; 115(11):1617-1628. PubMed ID: 30590389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.